TrialDiabetes care2016
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies.
John B Buse et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
156 papers cite itlatest 60 shown
this paperpooled ittrialcites it